Skip to content
← Catalog

Labiotech.eu · in vivo CAR-T momentum · AstraZeneca → EsoBiotec $1B

Industry press article tracking the wave of big pharma acquisitions in the in vivo CAR-T space · 含 EsoBiotec → AstraZeneca $1B (2025-03) interpretation。是 m622 reference acquisition $1B claim 的 primary public source。

Type
paper
Domain
oncology
Grade
conference
License
LIGHT_HOPE_proprietary
Provenance
m622_intel_seed_2026-05-16
evidence_grade
B
category
industry_press_M&A
status
verified
instance_tag
sunvax-antibody-2025
journal
Labiotech.eu (industry press)
year
2026
authors
abstract_snippet
Industry press article tracking the wave of big pharma acquisitions in the in vivo CAR-T space · 含 EsoBiotec → AstraZeneca $1B (2025-03) interpretation。是 m622 reference acquisition $1B claim 的 primary public source。
View at source ↗

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.